Logo

German Congress of Orthopaedics and Traumatology 2026 (DKOU 2026)

Deutsche Gesellschaft für Orthopädie und Unfallchirurgie (DGOU), Deutsche Gesellschaft für Orthopädie und Orthopädische Chirurgie (DGOOC), Deutsche Gesellschaft für Unfallchirurgie (DGU), Berufsverband für Orthopädie und Unfallchirurgie (BVOU)
20.-23.10.2026
Berlin

Meeting Abstract

The impact of location on de novo spondylodiscitis: Regions matter but are secondary to comorbidities

Julius Gerstmeyer - Klinik für Orthopädie und Unfallchirurgie, St. Josef Hospital, Bochum, Deutschland; Swedish Neuroscience Institute, Seattle, USA; Seattle Science Foundation, Seattle, USA
Anna Gorbacheva - Seattle Science Foundation, Seattle, USA
Clifford Pierre - Swedish Neuroscience Institute, Seattle, USA; Seattle Science Foundation, Seattle, USA
Cameron Hogsett - Swedish Neuroscience Institute, Seattle, USA
Nicholas Minissale - Swedish Neuroscience Institute, Seattle, USA; Seattle Science Foundation, Seattle, USA
Periklis Godolias - Klinik für Orthopädie, Universtitätsmedizin Essen, Essen, Deutschland
Tobias Schulte - Klinik für Orthopädie und Unfallchirurgie, St. Josef Hospital, Bochum, Deutschland
Thomas Armin Schildhauer - Chirurgische Poliklinik und Klinik, Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil Bochum, Bochum, Deutschland
Amir Abdul-Jabbar - Swedish Neuroscience Institute, Seattle, USA; Seattle Science Foundation, Seattle, USA
Rod Oskouian - Swedish Neuroscience Institute, Seattle, USA; Seattle Science Foundation, Seattle, USA
Jens Chapman - Swedish Neuroscience Institute, Seattle, USA; Seattle Science Foundation, Seattle, USA

Text

Objectives and questions: Primary spondylodiscitis (SD) cases surging in incidence globally remain a diagnostic and therapeutic challenge for physicians. The effect of lesion location on outcomes remains unclear. This study aims to assess the 90-day all-cause readmission rate in patients suffering from spondylodiscitis in different regions of the spine, with a secondary objective of comparing in-hospital mortality rates.

Material and methods: Utilizing the 2020 Nationwide Readmissions Database (NRD), USA, adult patients (>18 years) were selected by diagnosis with ICD-10 codes for primary spondylodiscitis. Patients were categorized by localization into eight groups, excluding multifocal patients. Comparative analysis and logistic regressions were performed.

Results: Among 5,547 patients, lumbar SD was most prevalent, followed by thoracic and lumbo-sacral regions. Cervical SD had the lowest readmission rate (31.3%) and lower odds versus lumbar SD (adjusted OR = 0.73; p = 0.007). Other regions showed no significant differences. In-hospital mortality varied by location. The sacral region, renal failure, and advanced age were the strongest mortality predictors.

Discussion and conclusions: While the incidence of spondylodiscitis varies by location on the spine, we found no significant differences in readmission rates across regions. However, there were substantial differences in in-hospital mortality rates. Comorbidities, particularly renal failure and advanced age, appear to outweigh spinal localization as risk factors for mortality and readmission.